Might SARS-CoV-2 Have Arisen via Serial Passage through an Animal Host or Cell Culture?: A potential explanation for much of the novel coronavirus' distinctive genome
- PMID: 32786014
- PMCID: PMC7435492
- DOI: 10.1002/bies.202000091
Might SARS-CoV-2 Have Arisen via Serial Passage through an Animal Host or Cell Culture?: A potential explanation for much of the novel coronavirus' distinctive genome
Abstract
Despite claims from prominent scientists that SARS-CoV-2 indubitably emerged naturally, the etiology of this novel coronavirus remains a pressing and open question: Without knowing the true nature of a disease, it is impossible for clinicians to appropriately shape their care, for policy-makers to correctly gauge the nature and extent of the threat, and for the public to appropriately modify their behavior. Unless the intermediate host necessary for completing a natural zoonotic jump is identified, the dual-use gain-of-function research practice of viral serial passage should be considered a viable route by which the novel coronavirus arose. The practice of serial passage mimics a natural zoonotic jump, and offers explanations for SARS-CoV-2's distinctive spike-protein region and its unexpectedly high affinity for angiotensin converting enzyme (ACE2), as well as the notable polybasic furin cleavage site within it. Additional molecular clues raise further questions, all of which warrant full investigation into the novel coronavirus's origins and a re-examination of the risks and rewards of dual-use gain-of-function research.
Keywords: COVID-19; SARS-CoV-2; coronavirus; gain-of-function; intermediate host; pandemic; serial passage; virology.
© 2020 Wiley Periodicals LLC.
Conflict of interest statement
The authors declare no conflict of interest.
Comment in
-
Clarification regarding the likely leak of a novel viral strain from a Soviet laboratory (referring to https://doi.org/10.1002/bies.202000091).Bioessays. 2021 Apr;43(4):e2100017. doi: 10.1002/bies.202100017. Epub 2021 Feb 12. Bioessays. 2021. PMID: 33576073 No abstract available.
References
-
- Wadman M., Couzin‐Frankel J., Kaiser J., Matacic C., Science 2020. - PubMed
-
- Wu C., Yang Y., Liu Y., Zhang P., Wang Y., Li H., Wang Q., Xu Y., Li Mingxue, Zheng M., Chen L., Furin, a Potential Therapeutic Target for COVID‐19, 8 Apr. 2020, 22:46, fairdomhub.org/publications/539. - PMC - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
